Mycoplasma Testing Market Strategic Outlook 2026–2036
According to FutureWise analysis, the Mycoplasma Testing market in 2026 is US$1.21 billion, and is expected to reach US$2.45 billion by 2036 at a CAGR of 7.31%. Mycoplasma contamination is a significant challenge in the fields of stem cell cultivation, tissue engineering, and biopharmaceutical production. These microorganisms can adversely affect the quality of biological products, making it...
0 Комментарии 0 Поделились 101 Просмотры 0 предпросмотр
Спонсоры